EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PSMD14 Stabilizes SLC7A11 to Ameliorate Glucocorticoid‐Induced Osteoporosis by Suppressing Osteocyte Ferroptosis

Yifeng Shi, Qian Tang, Sunren Sheng, Hongyi Jiang, Chen Jin, Chencheng Zhou, Chenglong Xie, Lin Zheng, Di Zhang, Hui Xu, Cong Xu, Haiwei Ma und 9 weitere

Advanced Science · 2025-08 · 12 (31)

DOI: 10.1002/advs.202414902 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 30.05.2025. Verfasst von Yifeng Shi und 20 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Orthopaedics of Zhejiang Province, Department of Orthopedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenz…. Hauptthemen laut MEDLINE: Ferroptosis, Osteocytes, Osteoporosis, Amino Acid Transport System y+. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China, Wenzhou Major Science and Technology Innovation Breakthrough, Zhejiang Province Medical and Health Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucocorticoid‐induced osteoporosis (GIOP) remains the most prevalent complication compromising bone health in patients undergoing glucocorticoid (GC) therapy. Despite its clinical significance, osteocyte death, a pivotal initiator of GC‐driven bone metabolic imbalance, has received insufficient attention. This study identifies ferroptosis, an iron‐dependent regulated cell death mechanism, as a novel pathological phenotype of osteocytes in GC microenvironments. Utilizing GPX4 conditional knockout mice and pharmacological ferroptosis inhibitors, this work demonstrates that osteocyte ferroptosis exacerbates GIOP progression. Metabolomic profiling reveals cystine insufficiency and glutathione depletion in GC‐treated osteocytes. Mechanistically, GCs directly impede the deubiquitinase PSMD14 from binding to SLC7A11, thereby promoting SLC7A11 ubiquitination and proteasomal degradation, which sharply diminishes cystine uptake. Bone‐targeting adeno‐associated virus‐mediated PSMD14 overexpression stabilized SLC7A11, attenuating both osteocytic ferroptosis and bone loss in GIOP mice. Through high‐throughput virtual screening, this work identifies Pantethine as a potent PSMD14 activator that enhances deubiquitinase activity, restores SLC7A11 expression in osteocytes, and mitigates osteoporosis. Collectively, this study elucidates the role and mechanism of osteocyte ferroptosis in GIOP pathogenesis and proposes PSMD14‐targeted therapy as a viable clinical strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisOsteocytesOsteoporosisAmino Acid Transport System y+GlucocorticoidsAnimalsMiceMice, KnockoutHumansMice, Inbred C57BL

Stichwörter der Autor:innen

PSMD14SLC7A11ferroptosisglucocorticoid‐induced osteoporosisubiquitination

Substanzen

Amino Acid Transport System y+GlucocorticoidsSlc7a11 protein, mouse

Autor:innen und Institutionen

  • Key Laboratory of Orthopaedics of Zhejiang Province, Department of Orthopedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
  • Department of Orthopedic Surgery, Shanghai Jiao Tong University Affiliated Shanghai Sixth People's Hospital, Shanghai, 200233, China.
  • Department of Orthopaedics Surgery, Lishui Central Hospital and Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, 323000, China.
  • Department of Orthopaedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310006, China.

ORCID-Profile: Gang Zheng

Förderung

  • Zhejiang Provincial Natural Science Foundation of China
  • Wenzhou Major Science and Technology Innovation Breakthrough
  • Zhejiang Province Medical and Health Science and Technology Project
  • National Natural Science Foundation of China

Zitieren

APA

Shi, Y., Tang, Q., Sheng, S., Jiang, H., Jin, C., Zhou, C., Xie, C., Zheng, L., Zhang, D., Xu, H., Xu, C., Ma, H., Xiang, G., Ni, W., Pan, X., Yang, L., Xu, H., Qian, Y., Wu, A., …, & Zheng, G. (2025). PSMD14 Stabilizes SLC7A11 to Ameliorate Glucocorticoid‐Induced Osteoporosis by Suppressing Osteocyte Ferroptosis. Advanced Science, 12(31). https://doi.org/10.1002/advs.202414902

Vancouver

Shi Y, Tang Q, Sheng S, Jiang H, Jin C, Zhou C, et al. PSMD14 Stabilizes SLC7A11 to Ameliorate Glucocorticoid‐Induced Osteoporosis by Suppressing Osteocyte Ferroptosis. Advanced Science. 2025;12(31). doi:10.1002/advs.202414902

BibTeX
@article{Shi2025,
  author = {Shi, Yifeng and Tang, Qian and Sheng, Sunren and Jiang, Hongyi and Jin, Chen and Zhou, Chencheng and Xie, Chenglong and Zheng, Lin and Zhang, Di and Xu, Hui and Xu, Cong and Ma, Haiwei and Xiang, Guangheng and Ni, Wenfei and Pan, Xiaoyun and Yang, Lei and Xu, Huazi and Qian, Yu and Wu, Aimin and Wang, Xiangyang and Zheng, Gang},
  title = {PSMD14 Stabilizes SLC7A11 to Ameliorate Glucocorticoid‐Induced Osteoporosis by Suppressing Osteocyte Ferroptosis},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {31},
  doi = {10.1002/advs.202414902}
}
Kostenlos starten →